Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Control Study of Cidan Capsule Combined With Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma

NCT02253511 is registered in ClinicalTrials.gov with Zheng Donghai as lead sponsor.

NCT NCT02253511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02253511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Control Study of Cidan Capsule Combined With Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Lead sponsor
Zheng Donghai
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2014
Completion date
July 31, 2017
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma